(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEUROKAIRE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

NEUROKAIRE

ST13

US500000097772043

Class

44

Filing

97772043

Registration

7368803

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

18

Latest update

04/23/2024

Trademark type

Combined

Nice classes

44

Filing date

01/29/2023

Registration date

04/23/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/23/2024

Last transaction

04/23/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

07/26/2022

First use in commerce

07/26/2022

Drawing code

3

Owner type

99

Owner location

Kearny, NJ

Examiner

SPARACINO, MARK

Law office

L30

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "NEUROKAIRE" with the diacritic dot of "I" represented in the form of a plus sign.

Holders and representatives

Holders

GenetikaPlus Ltd.

Representatives

GenetikaPlus Ltd.

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Genetic testing for medical purposes; Medical testing for diagnostic or treatment purposes in the field of central nervous system diseases; Medical testing services relating to the diagnosis and treatment of disease; Medical diagnostic testingmonitoring and reporting services

Publications

History of USPTO decisions and trademark events.

18 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/23/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/23/2024

DOCK

ASSIGNED TO EXAMINER

03/29/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

03/19/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/18/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/04/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/04/2024

IUAF

USE AMENDMENT FILED

02/12/2024

EISU

TEAS STATEMENT OF USE RECEIVED

02/12/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

01/30/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/05/2023

PUBO

PUBLISHED FOR OPPOSITION

12/05/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/15/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/30/2023

DOCK

ASSIGNED TO EXAMINER

10/26/2023

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

02/17/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/16/2023

NWAP

NEW APPLICATION ENTERED

02/01/2023

Continuous trademark protection

Get notified about every new filing that threatens NEUROKAIRE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.